Granules India Ltd. — Capital/Financing Update 2020

Feb 4, 2020

REGISTERED OFFICE

GRANULES INDIA LTD., 2nd Floor, 3rd Block, My Home Hub, Madhapur, Hyderabad - 500 081, Telangana, INDIA. Tel: +91 40 30660000, , Fax: +91 40 23115145, y mail@ granulesindia.com, indi indi www. CIN: L24110TG1991PLC012471 —_

Dated ; February 04, 2020

To, National Stock Exchange of India Limited BSE Limited Symbol: NSE: GRANULES; BSE: 532482

Sub: Update on sale of Company's Stake in Granules-Biocause Pharmaceutical Co. Limited, Joint Venture Company

Dear Sir,

Further to our letter dated October 14, 2019 and December 13, 2019 intimating the divestment of the entire stake of the Company in Granules-Biocause Pharmaceutical Co. Limited, an overseas Joint Venture Company situated in China for a total consideration of RMB 109 million and pursuant to the Listing Regulations, we write to inform you that the transaction is completed and Granules-Biocause Pharmaceutical Co. Limited is ceased to be the Joint Venture Company of Granules India Limited.

This is for your information and dissemination to the members of the exchange.

Thanking You.

Yours faithfully,

For GRANULES INDIA LIMITED

Yy CHAITANYA TUMMALA-

(COMPANY SECRETARY & COMPLIANCE OFFICER)